P = NS) (Figure 1F, gray bars)
Semaglutide, also known by the brand names Wegovy and Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to lower blood sugar levels, weight loss, and to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart disease
For people who use one of the two new GLP-1s, semaglutide (Wegovy) or tirzepatide (Zepbound) to lose weight, the results can vary from person to person
Evelyn Attia, MD, director of the Center for Eating Disorders at NewYork-Presbyterian, says people whove struggled with eating disorders or restrictive dieting should avoid taking GLP-1s
The support and guidance Ive received have truly given me my life back
Medical Conditions: Conditions like PCOS, insulin resistance, or thyroid disorders can influence outcomes